TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers

Several C2 domain-containing proteins play key roles in tumorigenesis, signal transduction, and mediating protein–protein interactions. Tandem C2 domains nuclear protein (TC2N) is a tandem C2 domain-containing protein that is differentially expressed in several types of cancers and is closely associ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hanyang Li, He Fang, Li Chang, Shuang Qiu, Xiaojun Ren, Lidong Cao, Jinda Bian, Zhenxiao Wang, Yi Guo, Jiayin Lv, Zhihui Sun, Tiejun Wang, Bingjin Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/a944dbfad2144ca6be63a06a015a27e5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a944dbfad2144ca6be63a06a015a27e5
record_format dspace
spelling oai:doaj.org-article:a944dbfad2144ca6be63a06a015a27e52021-12-02T06:03:59ZTC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers1664-322410.3389/fimmu.2021.764749https://doaj.org/article/a944dbfad2144ca6be63a06a015a27e52021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.764749/fullhttps://doaj.org/toc/1664-3224Several C2 domain-containing proteins play key roles in tumorigenesis, signal transduction, and mediating protein–protein interactions. Tandem C2 domains nuclear protein (TC2N) is a tandem C2 domain-containing protein that is differentially expressed in several types of cancers and is closely associated with tumorigenesis and tumor progression. Notably, TC2N has been identified as an oncogene in lung and gastric cancer but as a tumor suppressor gene in breast cancer. Recently, a large number of tumor-associated antigens (TAAs), such as heat shock proteins, alpha-fetoprotein, and carcinoembryonic antigen, have been identified in a variety of malignant tumors. Differences in the expression levels of TAAs between cancer cells and normal cells have led to these antigens being investigated as diagnostic and prognostic biomarkers and as novel targets in cancer treatment. In this review, we summarize the clinical characteristics of TC2N-positive cancers and potential mechanisms of action of TC2N in the occurrence and development of specific cancers. This article provides an exploration of TC2N as a potential target for the diagnosis and treatment of different types of cancers.Hanyang LiHanyang LiHe FangLi ChangShuang QiuXiaojun RenLidong CaoJinda BianZhenxiao WangYi GuoJiayin LvZhihui SunTiejun WangBingjin LiFrontiers Media S.A.articleTC2Ntumor-associated antigens (TAAs)cancersignal pathwaymolecular mechanismfunctional characterizationImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic TC2N
tumor-associated antigens (TAAs)
cancer
signal pathway
molecular mechanism
functional characterization
Immunologic diseases. Allergy
RC581-607
spellingShingle TC2N
tumor-associated antigens (TAAs)
cancer
signal pathway
molecular mechanism
functional characterization
Immunologic diseases. Allergy
RC581-607
Hanyang Li
Hanyang Li
He Fang
Li Chang
Shuang Qiu
Xiaojun Ren
Lidong Cao
Jinda Bian
Zhenxiao Wang
Yi Guo
Jiayin Lv
Zhihui Sun
Tiejun Wang
Bingjin Li
TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers
description Several C2 domain-containing proteins play key roles in tumorigenesis, signal transduction, and mediating protein–protein interactions. Tandem C2 domains nuclear protein (TC2N) is a tandem C2 domain-containing protein that is differentially expressed in several types of cancers and is closely associated with tumorigenesis and tumor progression. Notably, TC2N has been identified as an oncogene in lung and gastric cancer but as a tumor suppressor gene in breast cancer. Recently, a large number of tumor-associated antigens (TAAs), such as heat shock proteins, alpha-fetoprotein, and carcinoembryonic antigen, have been identified in a variety of malignant tumors. Differences in the expression levels of TAAs between cancer cells and normal cells have led to these antigens being investigated as diagnostic and prognostic biomarkers and as novel targets in cancer treatment. In this review, we summarize the clinical characteristics of TC2N-positive cancers and potential mechanisms of action of TC2N in the occurrence and development of specific cancers. This article provides an exploration of TC2N as a potential target for the diagnosis and treatment of different types of cancers.
format article
author Hanyang Li
Hanyang Li
He Fang
Li Chang
Shuang Qiu
Xiaojun Ren
Lidong Cao
Jinda Bian
Zhenxiao Wang
Yi Guo
Jiayin Lv
Zhihui Sun
Tiejun Wang
Bingjin Li
author_facet Hanyang Li
Hanyang Li
He Fang
Li Chang
Shuang Qiu
Xiaojun Ren
Lidong Cao
Jinda Bian
Zhenxiao Wang
Yi Guo
Jiayin Lv
Zhihui Sun
Tiejun Wang
Bingjin Li
author_sort Hanyang Li
title TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers
title_short TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers
title_full TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers
title_fullStr TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers
title_full_unstemmed TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers
title_sort tc2n: a novel vital oncogene or tumor suppressor gene in cancers
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/a944dbfad2144ca6be63a06a015a27e5
work_keys_str_mv AT hanyangli tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT hanyangli tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT hefang tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT lichang tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT shuangqiu tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT xiaojunren tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT lidongcao tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT jindabian tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT zhenxiaowang tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT yiguo tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT jiayinlv tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT zhihuisun tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT tiejunwang tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
AT bingjinli tc2nanovelvitaloncogeneortumorsuppressorgeneincancers
_version_ 1718400068132798464